Memorial Sloan Kettering Cancer Center Management of Treatment-Related Adverse Events Symposium 2020

Description

+ Include: 16 videos + 18 pdfs, size: 5.33 GB

+ Target Audience: cytotoxic chemotherapies, targeted therapies, immunotherapies symposium includes MDs, PAs, NPs, RNs

+ Sample video: contact me for sample video

+ Information:

Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.

2020 Symposium Highlights

• Therapy-related adverse events will affect the majority of cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
• With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention.
• Lectures focused on immune-related adverse events will describe the clinical presentation, diagnosis, and management strategies for the oncology healthcare provider.
• Up-to-date information will be presented on adverse event mechanisms and management from specialists in the most commonly affected organ systems.
• Practical strategies to identify patients at high risk will be highlighted, with strategies to direct patients towards the most efficient therapies based on healthcare providers.
• New strategies to monitor and manage symptoms of patients on active anticancer treatment will be discussed including patient-reported outcomes and teleoncology visits.

The target audience for this symposium includes MDs, PAs, NPs, RNs, Pharmacists, and other healthcare professionals treating cancer patients and their associated symptoms.

This course is endorsed by the Multinational Association of Supportive Care in Cancer.

1. Recognize the clinical presentation and impact on quality of life of treatment-related adverse events
2. Understand mechanisms to identify and triage patients at high risk for the development of toxicities
3. Discuss procedures and clinical strategies to prevent and treat adverse events in patients with cancer

+ Topics:

Adverse_2020Brochure.pdf
Day 2 Welcome and Introduction.mp4
Day 2 Welcome and Introduction.pdf
Immune Related Adverse Events.mp4
Immune Related Adverse Events.pdf
Insight Care.mp4
Insight Care.pdf
Integrative Medicine to Manage Adverse Events.mp4
Integrative Medicine to Manage Adverse Events.pdf
Management of Cardiac Adverse Events.mp4
Management of Cardiac Adverse Events.pdf
Management of Chemotherapy Induced Neuropathy.mp4
Management of Chemotherapy Induced Neuropathy.pdf
Management of Coagulopathies.mp4
Management of Coagulopathies.pdf
Management of Dermatologic Adverse Events.mp4
Management of Dermatologic Adverse Events.pdf
Management of Diarrhea and Colitis.mp4
Management of Diarrhea and Colitis.pdf
Management of Endocrine Adverse Events.mp4
Management of Endocrine Adverse Events.pdf
Management of Female Sexual Dysfunction After Cancer Treatment.pdf
Management of Hypertension and Cardiotoxicity.mp4
Management of Hypertension and Cardiotoxicity.pdf
Management of Male Sexual Dysfunction.pdf
Management of Neurologic Adverse Events.mp4
Management of Neurologic Adverse Events.pdf
Management of Rheumatologic Adverse Events.mp4
Management of Rheumatologic Adverse Events.pdf
Management of Sexual Dysfunction in Women and Men.mp4
Symptom Care Clinics.mp4
Symptom Care Clinics.pdf
Welcome and Introduction- Importance of Adverse Events.mp4
Welcome and Introduction- Importance of Adverse Events.pdf